… Japanese population dyspepsia was the most common AE during treatment with dabigatran…
In conclusion, the efficacy and safety profiles of dabigatran for Japanese AF patients at high …

… the same as those for the overall study population [7]. … and safety of dabigatran treatment
in “real-world” Japanese NVAF … and safety of dabigatran versus warfarin in Japanese NVAF …

… The aims of this study were to assess the patterns of oral anticoagulant (OAC) prescription
in Japanese patients with NVAF and compare the effectiveness and safety of dabigatran and …

… that dabigatran was the first launched NOAC in Japan. The PMS study will be continued
until March 2016 and the final analyses on the safety and effectiveness are due to be reported. …

… This study was conducted in Japanese patients; thus, the findings cannot be generalized to
other ethnic populations. Future studies should compare uninterrupted DOAC and minimally …

… of patients prescribed dabigatran and other … of Japanese patients with NVAF started on
dabigatran and other antithrombotics as their initial treatment by using data from the J-dabigatran …

… complications after dabigatran administration have been reported in some Japanese patients
[… the efficacy and safety of anticoagulation with dabigatran in Japanese patients with NVAF. …

… to investigate the safety and effectiveness of long-term dabigatran use in patients with …
Dabigatran Surveillance, we further evaluated the long-term safety and effectiveness of dabigatran …

… efficacy and safety of dabigatran compared with Warfarin. Second, dabigatran was prescribed
… This means that our results cannot be directly extrapolated to all the population. Third, we …

… accumulate data on the Japanese population for more detailed assessment. In conclusion,
in the current use of DOACs in Japanese patients with NVAF, dabigatran had a significantly …